Evidence map›Paper›PMID 25658432›Full record

ArticlePloS one2015

β-Hydroxy-β-methylbutyrate (HMB) normalizes dexamethasone-induced autophagy-lysosomal pathway in skeletal muscle.

María D Girón, Jose D Vílchez, Sathyavageeswaran Shreeram, Rafael Salto, Manuel Manzano, Elena Cabrera, Nefertiti Campos, Neile K Edens, Ricardo Rueda, Jose M López-Pedrosa

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 63 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. International society of sports nutrition position stand: β-hydroxy-β-methylbutyrate (HMB).Journal of the International Society of Sports Nutrition · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Multiomics-Identified Intervention to Restore Ethanol-Induced Dysregulated Proteostasis and Secondary Sarcopenia in Alcoholic Liver Disease.Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

María D GirónDepartment of Biochemistry and Molecular Biology II, University of Granada, Granada, Spain.
Jose D VílchezDepartment of Biochemistry and Molecular Biology II, University of Granada, Granada, Spain.
Sathyavageeswaran ShreeramAbbott Nutrition R&D, Singapore, Singapore.
Rafael SaltoDepartment of Biochemistry and Molecular Biology II, University of Granada, Granada, Spain.
Manuel ManzanoAbbott Nutrition R&D, Granada, Spain.
Elena CabreraDepartment of Biochemistry and Molecular Biology II, University of Granada, Granada, Spain.
Nefertiti CamposAbbott Nutrition R&D, Granada, Spain.
Neile K EdensAbbott Nutrition R&D, Columbus, Ohio, United States of America.
Ricardo RuedaAbbott Nutrition R&D, Granada, Spain.
Jose M López-PedrosaAbbott Nutrition R&D, Granada, Spain.
Abbott (Spain) · ESUniversidad de Granada · ESAbbott Nutrition (United States)Abbott (Singapore) · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dexamethasone-induced muscle atrophy is due to an increase in protein breakdown and a decrease in protein synthesis, associated with an over-stimulation of the autophagy-lysosomal pathway. These effects are mediated by alterations in IGF-1 and PI3K/Akt signaling. In this study, we have investigated the effects of β-Hydroxy-β-methylbutyrate (HMB) on the regulation of autophagy and proteosomal systems. Rats were treated during 21 days with dexamethasone as a model of muscle atrophy. Co-administration of HMB attenuated the effects promoted by dexamethasone. HMB ameliorated the loss in body weight, lean mass and the reduction of the muscle fiber cross-sectional area (shrinkage) in gastrocnemius muscle. Consequently, HMB produced an improvement in muscle strength in the dexamethasone-treated rats. To elucidate the molecular mechanisms responsible for these effects, rat L6 myotubes were used. In these cells, HMB significantly attenuated lysosomal proteolysis induced by dexamethasone by normalizing the changes observed in autophagosome formation, LC3 II, p62 and Bnip3 expression after dexamethasone treatment. HMB effects were mediated by an increase in FoxO3a phosphorylation and concomitant decrease in FoxO transcriptional activity. The HMB effect was due to the restoration of Akt signaling diminished by dexamethasone treatment. Moreover, HMB was also involved in the regulation of the activity of ubiquitin and expression of MurF1 and Atrogin-1, components of the proteasome system that are activated or up-regulated by dexamethasone. In conclusion, in vivo and in vitro studies suggest that HMB exerts protective effects against dexamethasone-induced muscle atrophy by normalizing the Akt/FoxO axis that controls autophagy and ubiquitin proteolysis.

Indexed as

AnimalsAutophagyDexamethasoneGlucocorticoidsLysosomesMaleMuscle Fibers, SkeletalMuscle, SkeletalMuscle StrengthMuscular AtrophyPhosphorylationProteasome Endopeptidase ComplexProteolysisRatsRats, Sprague-DawleySignal Transductionbeta-hydroxyisovaleric acidDexamethasoneGlucocorticoidsProteasome Endopeptidase ComplexValerates

Identifiers

PMID25658432
PMCPMC4319954
OpenAlexW2050404608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.